Launch of ScanNav Anatomy: PNB Trainer

RNS Number : 6886R
Intelligent Ultrasound Group PLC
10 March 2021
 

10 March 2021

Intelligent Ultrasound Group plc

("IUG" or the "Company")

 

Launch of ScanNav Anatomy: Peripheral Nerve Block Trainer

 

Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound artificial intelligence (AI) software and simulation company, announces the UK launch of the ScanNav Anatomy: Peripheral Nerve Block Trainer ("ScanNav PNB Trainer").

 

The ScanNav PNB Trainer is a real-time training system which uses the latest AI technology to automatically highlight the key structures on the live ultrasound image to aid in the teaching of peripheral nerve blocks. Peripheral nerve blocks (PNBs) are an effective form of regional anaesthetic but require a high level of skill to recognise the ultrasonic appearance of anatomically relevant structures.

 

The ScanNav PNB Trainer has been designed to teach less experienced clinicians how to perform the key nerve blocks. It is compatible with the majority of ultrasound machines in anaesthesiology  and comes equipped with a complete range of block-specific training videos using 3D animation to show the relationship between probe position and sonoanatomy.

 

Nicholas Sleep, CTO of Intelligent Ultrasound Group plc, commented: "We're delighted to be launching the ScanNav PNB Trainer in the UK. The AI-based software helps both trainees and their trainers by automatically highlighting the key anatomical structures needed to locate the correct block site. This makes it much easier to teach a block and also allows trainees to practice in a non-clinical environment without time pressure. The system is the first product in the Group's simulation range to benefit from our clinical AI research and development programme."

 

For further information, please contact:

 

Intelligent Ultrasound Group plc 

www. intelligentultrasound.com

Stuart Gall, CEO 
Helen Jones, CFO

Tel: +44 (0)29 2075 6534 



Cenkos Securities - Nominated Advisor and Broker

Tel:  +44 (0)20 7397 8900 

Giles Balleny (Corporate Finance)


Dale Bellis / Julian Morse (Sales) 




Walbrook PR 

Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

 

About Intelligent Ultrasound Group

 

Intelligent Ultrasound (AIM: IUG) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market. Based in Cardiff in the UK and Atlanta in the US, the Group operates two divisions:

 

Clinical AI Division

 

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in the market include ScanNav Assist, which uses machine-learning based algorithms to automatically identify and grade ultrasound images. GE Healthcare's SonoLyst software on their Voluson SWIFT ultrasound machine incorporates the ScanNav Assist AI technology and has received 510(k) clearance from the FDA for sale in the USA. SonoLyst is the world's first fully integrated AI tool that recognises the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging.

 

Products in development include ScanNav Anatomy PNB, which aims to simplify ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting software for a range of medical procedures. ScanNav Anatomy has been submitted for CE and FDA regulatory approval.

 

Simulation Division 

 

Focusses on hi-fidelity ultrasound education and training through simulation.  Its three main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator and the BodyWorks Eve Point of Care and Emergency Medicine training simulator. To dateover 1,000 simulators have been sold to over 600 medical institutions around the world.

 

www.intelligentultrasound.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGAWUPGGCB
UK 100

Latest directors dealings